Log In
BCIQ
Print this Print this
 

HCV NS5B polymerase

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting HCV NS5B polymerase

BCIQ
Print ChartPrint this
Marketed, 2 Approved, 1 Registration, 1 Phase II, 9 Phase I/II, 1 Phase I, 5 Preclinical, 4
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIRegistrationApprovedMarketed
Infectious

4

5

1

9

1

1

2




 Products Targeting HCV NS5B polymerase
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

22

$22,578.8M

$19,640.7M

$2,400.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today